Next Generation RNA Sequencing (NGS) Market Research Report – Segmented By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, and Single-Molecule Real-Time Sequencing), By Application (De Novo Transcriptome Assembly, Variant calling and Transcriptome Epigenetics, Small RNA-Sequencing, and Expression Profiling Analysis) By Sample Source (Environmental/Microbial, Animal, Plant, and Human), By Product & Service (Sample Preparation Products, RNA-Sequencing Services, RNA Sequencing Platforms & Consumables, Data Analysis, Storage, and Management), By End-User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research & Academia, and Others); and Region- Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. Next Generation RNA Sequencing (NGS) Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Next Generation RNA Sequencing (NGS) Market – Executive Summary
2.1    Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.2.1    Demand Side
2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Next Generation RNA Sequencing (NGS) Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Next Generation RNA Sequencing (NGS) Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
4.5.1    Bargaining Power of Suppliers
4.5.2    Bargaining Powers of Customers
4.5.3    Threat of New Entrants
4.5.4    Rivalry among Existing Players
4.5.5    Threat of Substitutes 
Chapter 5. Next Generation RNA Sequencing (NGS) Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Next Generation RNA Sequencing (NGS) Market – By Technology
6.1    Introduction/Key Findings   
6.2    Sequencing by Synthesis
6.3    Ion Semiconductor Sequencing
6.4    Nanopore Sequencing
6.5    Single-Molecule Real-Time Sequencing
6.6    Y-O-Y Growth trend Analysis By Technology
6.7    Absolute $ Opportunity Analysis By Technology, 2023-2030 
Chapter 7. Next Generation RNA Sequencing (NGS) Market – By Application
7.1    Introduction/Key Findings   
7.2    De Novo Transcriptome Assembly
7.3    Variant calling and Transcriptome Epigenetics
7.4    Small RNA-Sequencing
7.5    Expression Profiling Analysis
7.6    Y-O-Y Growth  trend Analysis By Application
7.7    Absolute $ Opportunity Analysis By Application, 2023-2030 
Chapter 8. Next Generation RNA Sequencing (NGS) Market – By Sample Source
8.1    Introduction/Key Findings   
8.2    Environmental/Microbial
8.3    Animal
8.4    Plant
8.5    Human
8.6    Y-O-Y Growth trend Analysis By Sample Source
8.7    Absolute $ Opportunity Analysis By Sample Source, 2023-2030
Chapter 9. Next Generation RNA Sequencing (NGS) Market – By Product & Service
9.1    Introduction/Key Findings   
9.2    Sample Preparation Products
9.3    RNA-Sequencing Services
9.4    RNA Sequencing Platforms & Consumables
9.5    Data Analysis, Storage, and Management
9.6    Y-O-Y Growth trend Analysis By Product & Service
9.7    Absolute $ Opportunity Analysis By Product & Service, 2023-2030

Chapter 10. Next Generation RNA Sequencing (NGS) Market – By End-User
10.1    Introduction/Key Findings   
10.2    Hospitals & Clinics
10.3    Pharmaceutical & Biotechnology Companies
10.4    Research & Academia
10.5    Others
10.6    Y-O-Y Growth trend Analysis By End-User
10.7    Absolute $ Opportunity Analysis By End-User, 2023-2030 
Chapter 11. Next Generation RNA Sequencing (NGS) Market, By Geography – Market Size, Forecast, Trends & Insights
11.1    North America
              11.1.1    By Country
                            11.1.1.1    U.S.A.
                            11.1.1.2    Canada
                            11.1.1.3    Mexico
              11.1.2    By Technology
                            11.1.2.1    By Application
              11.1.3    By Sample Source
              11.1.4    By End-User
              11.1.5    Countries & Segments - Market Attractiveness Analysis
11.2    Europe
              11.2.1    By Country
                            11.2.1.1    U.K
                            11.2.1.2    Germany
                            11.2.1.3    France
                            11.2.1.4    Italy
                            11.2.1.5    Spain
                            11.2.1.6    Rest of Europe
              11.2.2    By Technology
              11.2.3    By Application
              11.2.4    By Sample Source
              11.2.5    By Product & Service
              11.2.6    By End-User
              11.2.7    Countries & Segments - Market Attractiveness Analysis
11.3    Asia Pacific
              11.3.1    By Country
                            11.3.1.1    China
                            11.3.1.2    Japan
                            11.3.1.3    South Korea
                            11.3.1.4    India      
                            11.3.1.5    Australia & New Zealand
                            11.3.1.6    Rest of Asia-Pacific
              11.3.2    By Technology
              11.3.3    By Application
              11.3.4    By Sample Source
              11.3.5    By Product & Service
              11.3.6    By End-User
              11.3.7    Countries & Segments - Market Attractiveness Analysis
11.4    South America
              11.4.1    By Country
                            11.4.1.1    Brazil
                            11.4.1.2    Argentina
                            11.4.1.3    Colombia
                            11.4.1.4    Chile
                            11.4.1.5    Rest of South America
              11.4.2    By Technology
              11.4.3    By Application
              11.4.4    By Sample Source
              11.4.5    By Product & Service
              11.4.6    By End-User
              11.4.7    Countries & Segments - Market Attractiveness Analysis
11.5    Middle East & Africa
              11.5.1    By Country
                            11.5.1.1    United Arab Emirates (UAE)
                            11.5.1.2    Saudi Arabia
                            11.5.1.3    Qatar
                            11.5.1.4    Israel
                            11.5.1.5    South Africa
                            11.5.1.6    Nigeria
                            11.5.1.7    Kenya
                            11.5.1.8    Egypt
                            11.5.1.9    Rest of MEA
              11.5.2    By Technology
              11.5.3    By Application
              11.5.4    By Sample Source
              11.5.5    By Product & Service
              11.5.6    By End-User
              11.5.7    Countries & Segments - Market Attractiveness Analysis 
Chapter 12. Next Generation RNA Sequencing (NGS) Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
12.1    Genewiz
12.2    Illumina
12.3    Biocompare
12.4    Integrated DNA Technologies
12.5    Nucleome Informatics
12.6    Qiagen
12.7    Thermo Fisher Scientific
12.8    CD Genomics
12.9    BGI Genomics
12.10    Novogene
12.11    Eurofins Genomics

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800

Frequently Asked Questions

Next Generation RNA Sequencing (NGS) Market was valued at USD 2.89 billion and is projected to reach a market size of USD 10.57 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 17.6%. 

The increasing demand for personalized medicine and Technological advancements in sequencing technologies are the market drivers of the Next Generation RNA Sequencing (NGS) market.

Environmental/Microbial, Animal, Plant, and Human, are the segments under the Next Generation RNA Sequencing (NGS) Market by sample source.

 North America is the most dominant region for the Next Generation RNA Sequencing (NGS) Market.

 Genewiz, Illumina and Biocompare are few of the leading players in the Next Generation RNA Sequencing (NGS) Market.